Full Year 2025 ConvaTec Group PLC Earnings Call Transcript
Key Points
- Convatec Group PLC (CNVVY) achieved its fifth consecutive year of organic revenue sales growth within its target range.
- The company launched eight new products, contributing to its growth and market competitiveness.
- Operating margin expanded for the fourth consecutive year, reaching 22.3%, with a cumulative expansion of 460 basis points over four years.
- EPS growth was double-digit for the second year in a row, increasing by 16% in 2025.
- Strong cash flow enabled increased investment in growth initiatives and shareholder returns, including a $300 million share buyback.
- InnovaMatrix sales faced significant challenges, with a $30 million decrease due to market uncertainty and a CMS price rate reduction.
- The company recorded a non-cash accounting impairment of $72 million for the InnovaMatrix platform.
- The FDA issued a warning letter regarding the management of complaints and corrective actions, highlighting areas for improvement.
- Reimbursement dynamics continue to pose challenges, with anticipated headwinds impacting revenue growth.
- Execution issues, such as handoffs between functions, led to isolated back orders, indicating room for operational improvement.
Okay. Well, good morning, everybody, and welcome to ConvaTec's 2025 financial results presentation. Press harder. Usual disclaimers apply. So I'm going to start with an overview of 2025 and a little bit of what to expect, 2026. Fiona will present the financial results and guidance, and then I'll come back and talk about where we are on our strategic journey and what to expect next. And then we'll be very happy to take any questions you've got at the end.
2025 was a year of strong delivery. It was the fifth consecutive year that we delivered organic revenue sales growth within our target range. That was supported by eight new product launches that we've got underway at the moment. It was the fourth consecutive year of margin expansion, and it was the second year we grew EPS growth by double digit, and there's more to come on that. And the strong cash we generated enabled us to invest more to grow for the future and also to do some return to shareholders. So the growth is starting to compound. The flywheel is turning, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
